Humanigen Inc (HGENQ)

[10nisman]

The UK is, indeed, the one to watch.

The UK is one of the lowest payers for drugs in the world.

But to me, it makes very, very little sense to start commercialization with 100k or even 200k treatments. I doubt they could even satisfy the US National Stockpile requirements with that volume. I can understand that that may represent all that the company, by itself, can do. But why would our government agency partners not have recognized the unmet demand, and made it their focus to help Humanigen get lenz produced to meet that demand? We can produce 100's of millions of vaccines, but do no better than 100k or 200k patient treatments?

The answer is obvious.